(Q43036174)

12 November 2017

title

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b. (English)

1 reference

12 November 2017

1 reference

1 reference

16

Kazuaki Chayama

1 reference

12 November 2017

8

Michio Imamura

1 reference

12 November 2017

5

Masataka Tsuge

1 reference

12 November 2017

9

Shoichi Takahashi

1 reference

12 November 2017

2

Hidenori Ochi

1 reference

12 November 2017

10

C Nelson Hayes

1 reference

12 November 2017

7

Nobuhiko Hiraga

1 reference

12 November 2017

Yoshimasa Hashimoto

1

1 reference

12 November 2017

Hiromi Abe

3

1 reference

12 November 2017

Yasufumi Hayashida

4

1 reference

12 November 2017

Fukiko Mitsui

6

1 reference

12 November 2017

Waka Ohishi

11

1 reference

12 November 2017

Michaki Kubo

12

1 reference

12 November 2017

Tatsuhiko Tsunoda

13

1 reference

12 November 2017

Naoyuki Kamatani

14

1 reference

12 November 2017

Yusuke Nakamura

15

1 reference

12 November 2017

publication date

1 June 2011

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

83

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

981-988

1 reference

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

12 November 2017

cites work

1 reference

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

21 January 2018

1 reference

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.

21 January 2018

1 reference

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

21 January 2018

1 reference

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Host factors and failure of interferon-alpha treatment in hepatitis C virus

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

21 January 2018

1 reference

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

21 January 2018

1 reference

Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

21 January 2018

1 reference

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

21 January 2018

1 reference

Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences

21 January 2018

1 reference

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.

21 January 2018

1 reference

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

21 January 2018

1 reference

A high-throughput SNP typing system for genome-wide association studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.22028

1 reference

12 November 2017

1 reference